OA10402A - Spirostanyl glycosidal crystals - Google Patents

Spirostanyl glycosidal crystals Download PDF

Info

Publication number
OA10402A
OA10402A OA60970A OA60970A OA10402A OA 10402 A OA10402 A OA 10402A OA 60970 A OA60970 A OA 60970A OA 60970 A OA60970 A OA 60970A OA 10402 A OA10402 A OA 10402A
Authority
OA
OAPI
Prior art keywords
crystalline
spirostan
oxy
glycoside
bis
Prior art date
Application number
OA60970A
Other languages
English (en)
Inventor
J Douglas Allen
Richard A Buzon Sr
Michael P Deninno
Harry A Watson Jr
Jonathan B Zung
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of OA10402A publication Critical patent/OA10402A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA60970A 1994-08-30 1997-02-28 Spirostanyl glycosidal crystals OA10402A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29810694A 1994-08-30 1994-08-30

Publications (1)

Publication Number Publication Date
OA10402A true OA10402A (en) 2001-12-05

Family

ID=23149057

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60970A OA10402A (en) 1994-08-30 1997-02-28 Spirostanyl glycosidal crystals

Country Status (20)

Country Link
US (1) US5804562A (fr)
EP (1) EP0778846A1 (fr)
JP (1) JPH09510735A (fr)
KR (1) KR970705574A (fr)
AU (1) AU2265395A (fr)
BR (1) BR9503827A (fr)
CA (1) CA2198097A1 (fr)
CO (1) CO4480032A1 (fr)
FI (1) FI970828L (fr)
HR (1) HRP950459A2 (fr)
IL (1) IL115062A0 (fr)
MA (1) MA23651A1 (fr)
MX (1) MX9701525A (fr)
NO (1) NO970910D0 (fr)
OA (1) OA10402A (fr)
PE (1) PE47696A1 (fr)
PL (1) PL318937A1 (fr)
SI (1) SI9520092A (fr)
TR (1) TR199501065A2 (fr)
WO (1) WO1996006854A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL195897B1 (pl) * 1998-03-26 2007-11-30 Phytopharm Plc Zastosowanie smilageniny
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629295A (en) * 1992-06-26 1997-05-13 Pfizer Inc. Steroidal glycosides for treating hypercholesterolemia
US5698526A (en) * 1993-12-28 1997-12-16 Pfizer Inc. Steroidal glycosides

Also Published As

Publication number Publication date
NO970910L (no) 1997-02-27
US5804562A (en) 1998-09-08
SI9520092A (en) 1997-12-31
CA2198097A1 (fr) 1996-03-07
KR970705574A (ko) 1997-10-09
FI970828A7 (fi) 1997-02-27
MA23651A1 (fr) 1996-04-01
AU2265395A (en) 1996-03-22
CO4480032A1 (es) 1997-07-09
TR199501065A2 (tr) 1996-06-21
FI970828A0 (fi) 1997-02-27
JPH09510735A (ja) 1997-10-28
BR9503827A (pt) 1996-09-10
IL115062A0 (en) 1995-12-08
FI970828L (fi) 1997-02-27
PE47696A1 (es) 1996-11-12
EP0778846A1 (fr) 1997-06-18
MX9701525A (es) 1997-05-31
WO1996006854A1 (fr) 1996-03-07
HRP950459A2 (en) 1997-08-31
PL318937A1 (en) 1997-07-21
NO970910D0 (no) 1997-02-27

Similar Documents

Publication Publication Date Title
US5703052A (en) Sterodial glycosides for treating hypercholesterolemia
GB2033747A (en) Method and composition for treating psoriases with retinoyl compounds
CA2180148A1 (fr) Agents hypocholesterolemiques
US5760009A (en) Spirostanyl glycosidal crystalline monohydrate
OA10402A (en) Spirostanyl glycosidal crystals
US6150336A (en) Steroidal glycosides
CA1251784A (fr) Steroides esterifies en position 17 et thioesterifies en position 21, methode de preparation et usage comme medicaments
CA1114385A (fr) N-(mercaptoacyl)-histidine
US3845085A (en) Steroids of the pregnane series
CA1255293A (fr) Composes de 2 oxa- ou -aza-pregnane
EP0320253B1 (fr) 21-Alcoxy stéroides
CA1058610A (fr) 17a, 21-diesters de pregnanes
US4127589A (en) 4,5-Seco-steroids
NO945001L (no) Steroide glykosider for behandling av hyperkolestrolemi
CN1156458A (zh) 螺甾烷基糖苷晶体
JPH01316397A (ja) １１β，１７α，２１―トリヒドロキシ―１，４―プレグナジエン―３，２０―ジオン　２１―〔（Ｅ，Ｅ）―３，７，１１―トリメチル―２，６，１０―ドデカトリエノアート〕及びこれを含有する抗炎症剤